HIPK2 and acute myeloid leukemia: Few mutation were also found in human acute myeloid leukemias (AMLs), which lead to aberrant HIPK2 nuclear distribution with impairment of p53 apoptotic transcriptional activity [51], confirming the role of HIPK2 in p53 activation to counteract tumor growth.